Fig. 3: Evaluating the utility of PGS for confounder adjustment. | Nature Genetics

Fig. 3: Evaluating the utility of PGS for confounder adjustment.

From: Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design

Fig. 3: Evaluating the utility of PGS for confounder adjustment.

a, A DAG illustrates the causal structure between PGS, confounder (C), treatment (X) and outcome (Y). The PGS serves as an imperfect proxy variable for the confounder. The effects of the C on the exposure (X) and outcome (Y) are denoted as bCX and bCY, respectively. The true unconfounded effect of X on Y is bXY = 1. b, Simulation study—under this model (Methods), we changed the correlation between C and PGS simply by varying r and the effect of confounding factor C on X and Y by varying bCX and bCY. Under each condition, we measured the observed effect of X on Y, conditioned on PGS and calculated the bias as a percentage of the inflated effect of X on Y. \(\frac{{{b}_{{CX}}}^{2}}{{\mathrm{Var}}(X)}\) = \(\frac{{{b}_{{CY}}}^{2}}{{\mathrm{Var}}(Y)}\) = 0.1 for small confounding effect, 0.2 for small-medium confounding effect, 0.3 for medium-large confounding effect and 0.5 for large confounding effect. Under each condition, we carried out experiments for 100 iterations (each n = 100,000). Data are presented as mean values and 95% tolerance intervals (±1.96 × s.d.). These simulations show that even if PGS is strongly correlated with the confounder (that is, r2 = 0.5)—an unlikely scenario, given the correlation between PGS and traits is generally lower—correcting for PGS does not completely account for the bias introduced by the confounder.

Source data

Back to article page